Anti bacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus.

Background: Methicillin resistant Staphylococcus aureus (MRSA) continues to be one of the commonest pathogens encountered in clinical as well as laboratory practice. It has become a major health problem worldwide. Newer antimicrobials/agents are urgently needed to combat this problem MRSA resistance to various anti-staphylococcal agents.